查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1546288

全球植入診斷市場評估：依產品與服務、依技術、依植入類型、依應用、依最終用戶、依地區、機會、預測，2017-2031年

Transplant Diagnostics Market Assessment, By Product and Services, By Technology, By Transplant Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 246 Pages | 商品交期: 3-5個工作天內

價格

預計2024-2031年期間，全球移植診斷市場規模將以8.05%的年複合成長率擴大，從2023年的50.7522億美元成長到2031年的94.2873億美元。隨著移植手術數量的增加，移植診斷產品和服務的市場顯著成長。預計移植診斷市場在預測期內將繼續以驚人的速度成長。

移植診斷包括各種測試和程序，用於評估潛在的器官捐贈者和接受者、匹配捐贈者和接受者，以及監測移植器官是否出現排斥跡象。該市場主要是由器官移植需求不斷成長所推動的。疾病負擔的增加以及由此產生的器官移植需求，加上公眾對器官移植的認識不斷提高，推動移植數量的增加。隨著移植手術數量的增加，由於監管限制，移植診斷試劑的需求預計也會增加。市場進入者積極參與，透過聯盟、合併和創新產品發布等策略來促進市場成長，這進一步加強了移植診斷市場。

近年來，每年進行的器官移植手術數量大幅增加，達到歷史最高水準。這一成長是由於器官捐贈意識的提高、移植醫學的進步改善了結果、國家器官捐贈和移植系統的建立以及公眾意識的提高所推動的。根據美國器官採購和移植網路（OPTN）的資料，由於這些努力，2023年將進行超過46,000例器官移植，比前一年（2022年）增加8.7%。可用器官庫的擴大意味著更多的患者，包括數量不詳的患者，可以接受他們所需的挽救生命的移植手術。隨著移植手術數量的增加，對移植相關診斷的需求也預計會增加。這是因為移植診斷是移植手術的重要一環。

本報告調查了全球移植診斷市場，並提供了市場概述，以及依產品/服務、技術、移植類型、應用、最終用戶、地區的趨勢，以及進入市場的公司概況。

目錄

第1章 專案範圍與定義

第2章 研究方法

第3章 執行摘要

第4章 2017-2031年全球移植診斷市場展望

  • 市場規模分析與預測
  • 市佔率分析與預測
  • 2023年市場地圖分析
    • 依產品/服務
    • 依技術
    • 依移植類型
    • 依用途
    • 依最終用戶
    • 依地區

第5章 北美移植診斷市場展望，2017-2031

第6章 歐洲移植診斷市場展望，2017-2031

第7章 亞太移植診斷市場展望，2017-2031

第8章 南美洲移植診斷市場前景，2017-2031

第9章 中東與非洲移植診斷市場前景，2017-2031

第10章 供需分析

第11章 進出口分析

第12章 價值鏈分析

第13章 波特五力分析

第14章 PESTLE分析

第15章 價格分析

第16章 市場動態

第17章 市場趨勢與發展

第18章 監理架構與創新

第19章 專利狀況

第20章 個案研究

第21章 競爭態勢

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 名的公司的SWOT 分析
  • 前10名主要企業狀況
    • Becton Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Illumina Inc.
    • Immucor Transplant Diagnostics Inc.
    • Thermo Fisher Scientific Inc.
    • CareDx, Inc.
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories Inc.
    • BioMerieux S.A.
    • QIAGEN N.V.

第22章 策略建議

第23章 查詢及免責聲明

Product Code: MX11838

Global transplant diagnostics market is projected to witness a CAGR of 8.05% during the forecast period 2024-2031, growing from USD 5075.22 million in 2023 to USD 9428.73 million in 2031. The market for transplant diagnostic products and services is thriving significantly with the rising number of transplant procedures. The transplant diagnostics market is anticipated to keep growing at a notable pace during the forecast period.

Transplant diagnostics involves various tests and procedures used to assess potential organ donors and organ recipients, match donors to recipients, and monitor transplanted organs for any signs of rejection. The market is gaining significant traction due to the rising demand for organ transplants. The rising disease burden and subsequent need for organ transplants, combined with rising awareness about organ transplants among people, drives the rising number of transplants. With an increase in transplant procedures, the demand for transplant diagnostics is also anticipated to increase due to regulatory constraints. The active participation of market players to enhance market growth through tactics like collaborations, mergers, and innovative product launches further strengthens the market for transplant diagnostics. For instance, in September 2023, Hungarian molecular diagnostics firm Omixon Inc. introduced a new single-locus human leukocyte antigen (HLA) typing kit called NanoType Mono, based on nanopore sequencing. Similarly, Dutch company Genome Diagnostics B.V., a division of Eurobio Scientific SA, launched another product called NGS-Turbo, an assay designed for high-resolution HLA typing using Oxford Nanopore Technologies platforms.

High Demand for Organ Transplants

The organ transplant procedures performed annually have significantly increased in recent years, reaching new record highs. This growth is driven by several key factors, including a rise in both deceased and living organ donors due to growing awareness about organ donations, advances in transplant medicine that have improved outcomes, the establishment of a national organ donation and transplant system, heightened public awareness and voluntary registration of potential donors. As a result of these developments, according to the Organ Procurement and Transplantation Network (OPTN) of the United States, over 46,000 organ transplants were performed in 2023, recording an 8.7% increase from the prior year 2022. The expanding pool of available organs has allowed more patients, including underrepresented groups, to receive the lifesaving transplants they need. As the number of transplant procedures increases, the demand for transplant-associated diagnostics is anticipated to increase too, as transplant diagnostics is a crucial part of transplant procedures.

Technological Advancements Drive Market Growth

Artificial intelligence (AI) and machine learning have revolutionized transplant diagnostics by enabling the development of AI-powered diagnostic models that can analyze digitized biopsy specimens, improve assessments of transplanted organs, and reduce variability among diagnoses. Advanced imaging techniques provide detailed information about organ function and structure, improving early diagnosis of complications. Innovations in organ preservation, ventricular assist devices, artificial hearts, gene editing, customized organs, and robotic technology have significantly improved transplant outcomes and reduced patient complications. Market players have come up with several AI-based solutions for transplant diagnostics. For instance, in May 2024, Thermo Fisher Scientific Inc. launched a new CXCL10 testing service to aid in the management of kidney transplant patients. The non-invasive urine test can detect the CXCL10 chemokine, which may provide valuable information faster than currently used tests and help identify early signs of kidney transplant rejection. The test is expected to make post-transplant care more convenient and less invasive for the nearly 250,000 Americans living with a kidney transplant. According to Thermo Fisher, this lower-cost, non-invasive testing option can expand access to care and improve patient adherence, as the sample can be collected at any local clinic.

Dominance of Solid Organ Transplant Segment in Transplant Diagnostics Market

Solid organ transplants are the most common type of transplant procedure performed over a long period of time; while other transplant methods like stem cell and soft tissue transplants evolved in the last few decades at the commercial level, the solid organ transplant segment is anticipated to hold the largest share in the market. The kidney, liver, and skin are the most common organs to be transplanted. For instance, according to the Organ Procurement and Transplantation Network (OPTN) of the United States, 10,000 liver transplants and 3,000 lung transplants have been performed in 2023, within the United States, while the total number of organ transplants is above 46,000, in the same place only around 23,000 Hematopoietic Stem Cell Transplantation (HSCT), i.e., stem cell type of transplant were performed in the United States.

North America Dominates Transplant Diagnostics Market

North America is anticipated to lead in the transplant diagnostics market during the forecasted period owing to a highly aware population who knows about organ donation and transplantation very well. The United States and Canada are two major North American countries with well-structured healthcare systems and government initiatives to promote organ transplants. The United States contributes a significant share of revenue in the global market due to the high cost of procedures. The United States reached the milestone of 1 million organ transplants in 2022, and the number is still rising. As per the International Registry on Organ Donation and Transplantation, the United States transplant system saves more lives than any other country. The United States leads with the highest rates of deceased donors and kidney and liver transplants from deceased donors.

Future Market Scenario (2024-2031F)

Immunogenetics and pharmacogenomics are revolutionizing transplant diagnostics by enabling more precise donor matching, personalized immunosuppression dosing based on genetic factors, non-invasive rejection monitoring techniques, and targeted cellular therapies, leading to improved outcomes and reduced complications for transplant recipients. These advancements are transforming the future of transplant care through personalized, data-driven approaches that leverage genetic insights. Key players in the market are also aligning themselves with this evolving technology through the launch of new products.

For instance, in June 2024, Omixon Inc., announced the launch of HolograFT One, a research-use-only kit and software designed for post-transplant monitoring using donor-derived cell-free DNA (dd-cfDNA). HolograFT One enables researchers to accurately quantify dd-cfDNA levels, which serve as a biomarker for detecting rejection in solid organ transplant recipients. This innovative solution combines a user-friendly sample preparation kit with advanced data analysis software, providing researchers with a comprehensive tool to monitor transplant health and potentially improve patient outcomes.

Key Players Landscape and Outlook

Becton Dickinson and Company, Bio-Rad Laboratories Inc., Illumina Inc., Immucor Transplant Diagnostics Inc., Thermo Fisher Scientific Inc., CareDx, Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories Inc., BioMerieux S.A., QIAGEN N.V. are some of the leading players in the transplant diagnostics market. The market witnessed some substantial market deals like mergers and collaborations to expand the market share of key players.

In May 2024, Werfen, S.A., announced the acquisition of Omixon Inc., a privately held company focused on Next Generation Sequencing (NGS) technologies for transplant diagnostics. The transaction, valued at approximately USD 25 million, is expected to be completed in 2024 and will allow Werfen to expand its portfolio of transplant diagnostics solutions. Omixon's expertise in bioinformatics, software engineering, and molecular biology will complement Werfen's strengths in transplant diagnostics, creating an opportunity to advance transplant diagnostics globally.

In April 2024, Eurofins, a global leader in bioanalytical testing, expanded its offerings in renal and transplant testing in the United States by acquiring Ascend Clinical LLC. This acquisition enhances Eurofins' capabilities in providing comprehensive testing solutions for kidney health and transplant patients.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Transplant Diagnostics Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product and Services
      • 4.2.1.1. Reagents and Consumables
      • 4.2.1.2. Instruments
      • 4.2.1.3. Software and Services
    • 4.2.2. By Technology
      • 4.2.2.1. Molecular Assay
        • 4.2.2.1.1. PCR-Based Molecular Assay
        • 4.2.2.1.2. Sequence-Based Molecular Assay
      • 4.2.2.2. Non-Molecular Assay
    • 4.2.3. By Transplant Type
      • 4.2.3.1. Solid Organ
      • 4.2.3.2. Stem Cell
      • 4.2.3.3. Soft Tissue
      • 4.2.3.4. Bone Marrow
    • 4.2.4. By Application
      • 4.2.4.1. Diagnostics
        • 4.2.4.1.1. Pre-Transplant
        • 4.2.4.1.2. Post-Transplant
      • 4.2.4.2. Research
    • 4.2.5. By End-user
      • 4.2.5.1. Hospitals and Transplant Centers
      • 4.2.5.2. Research Laboratories and Academic Institutions
      • 4.2.5.3. Independent Reference Laboratories
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia-Pacific
      • 4.2.6.4. South America
      • 4.2.6.5. Middle East and Africa
    • 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product and Services
    • 4.3.2. By Technology
    • 4.3.3. By Transplant Type
    • 4.3.4. By Application
    • 4.3.5. By End-user
    • 4.3.6. By Region

5. North America Transplant Diagnostics Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product and Services
      • 5.2.1.1. Reagents and Consumables
      • 5.2.1.2. Instruments
      • 5.2.1.3. Software and Services
    • 5.2.2. By Technology
      • 5.2.2.1. Molecular Assay
        • 5.2.2.1.1. PCR-Based Molecular Assay
        • 5.2.2.1.2. Sequence-Based Molecular Assay
      • 5.2.2.2. Non-Molecular Assay
    • 5.2.3. By Transplant Type
      • 5.2.3.1. Solid Organ
      • 5.2.3.2. Stem Cell
      • 5.2.3.3. Soft Tissue
      • 5.2.3.4. Bone Marrow
    • 5.2.4. By Application
      • 5.2.4.1. Diagnostics
        • 5.2.4.1.1. Pre-Transplant
        • 5.2.4.1.2. Post-Transplant
      • 5.2.4.2. Research
    • 5.2.5. By End-user
      • 5.2.5.1. Hospitals and Transplant Centers
      • 5.2.5.2. Research Laboratories and Academic Institutions
      • 5.2.5.3. Independent Reference Laboratories
    • 5.2.6. By Country Share
      • 5.2.6.1. United States
      • 5.2.6.2. Canada
      • 5.2.6.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Transplant Diagnostics Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product and Services
          • 5.3.1.2.1.1. Reagents and Consumables
          • 5.3.1.2.1.2. Instruments
          • 5.3.1.2.1.3. Software and Services
        • 5.3.1.2.2. By Technology
          • 5.3.1.2.2.1. Molecular Assay
          • 5.3.1.2.2.1.1. PCR-Based Molecular Assay
          • 5.3.1.2.2.1.2. Sequence-Based Molecular Assay
          • 5.3.1.2.2.2. Non-Molecular Assay
        • 5.3.1.2.3. By Transplant Type
          • 5.3.1.2.3.1. Solid Organ
          • 5.3.1.2.3.2. Stem Cell
          • 5.3.1.2.3.3. Soft Tissue
          • 5.3.1.2.3.4. Bone Marrow
        • 5.3.1.2.4. By Application
          • 5.3.1.2.4.1. Diagnostics
          • 5.3.1.2.4.1.1. Pre-Transplant
          • 5.3.1.2.4.1.2. Post-Transplant
          • 5.3.1.2.4.2. Research
        • 5.3.1.2.5. By End-user
          • 5.3.1.2.5.1. Hospitals and Transplant Centers
          • 5.3.1.2.5.2. Research Laboratories and Academic Institutions
          • 5.3.1.2.5.3. Independent Reference Laboratories
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Transplant Diagnostics Market Outlook, 2017-2031F

    • 6.1.1. Germany
    • 6.1.2. France
    • 6.1.3. Italy
    • 6.1.4. United Kingdom
    • 6.1.5. Russia
    • 6.1.6. Netherlands
    • 6.1.7. Spain
    • 6.1.8. Poland

7. Asia-Pacific Transplant Diagnostics Market Outlook, 2017-2031F

    • 7.1.1. India
    • 7.1.2. China
    • 7.1.3. Japan
    • 7.1.4. Australia
    • 7.1.5. Vietnam
    • 7.1.6. South Korea
    • 7.1.7. Indonesia
    • 7.1.8. Philippines

8. South America Transplant Diagnostics Market Outlook, 2017-2031F

    • 8.1.1. Brazil
    • 8.1.2. Argentina

9. Middle East and Africa Transplant Diagnostics Market Outlook, 2017-2031F

    • 9.1.1. Saudi Arabia
    • 9.1.2. UAE
    • 9.1.3. South Africa
    • 9.1.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Becton Dickinson and Company
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 21.3.2. Bio-Rad Laboratories Inc.
    • 21.3.3. Illumina Inc.
    • 21.3.4. Immucor Transplant Diagnostics Inc.
    • 21.3.5. Thermo Fisher Scientific Inc.
    • 21.3.6. CareDx, Inc.
    • 21.3.7. F. Hoffmann-La Roche Ltd
    • 21.3.8. Abbott Laboratories Inc.
    • 21.3.9. BioMerieux S.A.
    • 21.3.10. QIAGEN N.V.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 2. Global Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 3. Global Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 4. Global Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 6. Global Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 7. Global Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 8. Global Transplant Diagnostics Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 10. North America Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 11. North America Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 12. North America Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 13. North America Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 14. North America Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 15. North America Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 16. North America Transplant Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 18. United States Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 19. United States Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 20. United States Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 21. United States Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 22. United States Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 23. United States Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 24. Canada Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 25. Canada Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 26. Canada Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 27. Canada Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 28. Canada Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 29. Canada Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 30. Canada Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 31. Mexico Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 32. Mexico Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 33. Mexico Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 34. Mexico Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 35. Mexico Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 36. Mexico Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 37. Mexico Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 38. Europe Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 39. Europe Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 40. Europe Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 41. Europe Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 42. Europe Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 43. Europe Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 44. Europe Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 45. Europe Transplant Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 47. Germany Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 48. Germany Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 49. Germany Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 50. Germany Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 51. Germany Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 52. Germany Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 53. France Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 54. France Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 55. France Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 56. France Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 57. France Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 58. France Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 59. France Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 60. Italy Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 61. Italy Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 62. Italy Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 63. Italy Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 64. Italy Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 65. Italy Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 66. Italy Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 67. United Kingdom Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 68. United Kingdom Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 69. United Kingdom Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 70. United Kingdom Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 71. United Kingdom Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 72. United Kingdom Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 73. United Kingdom Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 74. Russia Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 75. Russia Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 76. Russia Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 77. Russia Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 78. Russia Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 79. Russia Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 80. Russia Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 81. Netherlands Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 82. Netherlands Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 83. Netherlands Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 84. Netherlands Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 85. Netherlands Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 86. Netherlands Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 87. Netherlands Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 88. Spain Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 89. Spain Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 90. Spain Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 91. Spain Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 92. Spain Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 93. Spain Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 94. Spain Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 95. Turkey Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 96. Turkey Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 97. Turkey Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 98. Turkey Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 99. Turkey Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 100. Turkey Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 101. Turkey Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 102. Poland Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 103. Poland Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 104. Poland Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 105. Poland Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 106. Poland Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 107. Poland Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 108. Poland Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 109. South America Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 110. South America Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 111. South America Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 112. South America Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 113. South America Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 114. South America Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 115. South America Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 116. South America Transplant Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 117. Brazil Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 118. Brazil Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 119. Brazil Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 120. Brazil Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 121. Brazil Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 122. Brazil Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 123. Brazil Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 124. Argentina Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 125. Argentina Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 126. Argentina Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 127. Argentina Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 128. Argentina Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 129. Argentina Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 130. Argentina Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 131. Asia-Pacific Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 132. Asia-Pacific Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 133. Asia-Pacific Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 134. Asia-Pacific Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 135. Asia-Pacific Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 136. Asia-Pacific Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 137. Asia- Pacific Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 138. Asia-Pacific Transplant Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 139. India Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 140. India Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 141. India Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 142. India Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 143. India Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 144. India Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 145. India Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 146. China Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 147. China Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 148. China Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 149. China Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 150. China Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 151. China Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 152. China Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 153. Japan Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 154. Japan Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 155. Japan Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 156. Japan Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 157. Japan Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 158. Japan Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 159. Japan Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 160. Australia Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 161. Australia Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 162. Australia Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 163. Australia Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 164. Australia Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 165. Australia Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 166. Australia Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 167. Vietnam Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 168. Vietnam Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 169. Vietnam Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 170. Vietnam Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 171. Vietnam Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 172. Vietnam Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 173. Vietnam Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 174. South Korea Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 175. South Korea Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 176. South Korea Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 177. South Korea Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 178. South Korea Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 179. South Korea Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 180. South Korea Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 181. Indonesia Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 182. Indonesia Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 183. Indonesia Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 184. Indonesia Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 185. Indonesia Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 186. Indonesia Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 187. Indonesia Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 188. Philippines Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 189. Philippines Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 190. Philippines Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 191. Philippines Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 192. Philippines Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 193. Philippines Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 194. Philippines Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 195. Middle East & Africa Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 196. Middle East & Africa Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 197. Middle East & Africa Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 198. Middle East & Africa Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 199. Middle East & Africa Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 200. Middle East & Africa Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 201. Middle East & Africa Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 202. Middle East & Africa Transplant Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 203. Saudi Arabia Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 204. Saudi Arabia Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 205. Saudi Arabia Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 206. Saudi Arabia Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 207. Saudi Arabia Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 208. Saudi Arabia Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 209. Saudi Arabia Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 210. UAE Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 211. UAE Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 212. UAE Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 213. UAE Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 214. UAE Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 215. UAE Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 216. UAE Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 217. South Africa Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 218. South Africa Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
  • Figure 219. South Africa Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
  • Figure 220. South Africa Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 221. South Africa Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
  • Figure 222. South Africa Transplant Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 223. South Africa Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 224. By Product and Services Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 225. By Technology Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 226. By Transplant Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 227. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 228. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 229. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023